MedTrace Logo

Clinical Feasibility of a Conformal Ultrasound Blood Pressure Sensor

NCT05909605 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2023-12-05

No results posted yet for this study

Summary

Blood pressure (BP) monitoring is essential for managing cardiovascular diseases. Arterial line (A-line), the clinical gold standard for BP monitoring, is too invasive for routine measurements. The sphygmomanometer, on the other hand, is non-invasive but captures only discrete values. The recently introduced conformal ultrasound sensor offers non-invasive and continuous monitoring of BP, which can potentially improve the quality of patient care, but its accuracy has yet to be thoroughly validated. Here the investigators are working to validate the accuracy of a redesigned ultrasound sensor with enhanced reliability in BP measurements at-home and in clinics even under different interventions.

Conditions

  • Feasibility Study
  • Medical Device

Interventions

DEVICE

sphygmomanometer

Comparison to the ultrasound sensor

DEVICE

Arterial Line

Comparison to the ultrasound sensor

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-20
Primary Completion
2023-12-01
Completion
2023-12-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05909605 on ClinicalTrials.gov